4D Molecular Therapeutics, Inc.
FDMT
$4.11
-$0.17-3.97%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 424.88M | 501.89M | 541.95M | 525.91M | 288.23M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.06M | 8.87M | 10.69M | 9.68M | 8.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 434.93M | 510.76M | 552.63M | 535.59M | 296.59M |
|
|
|||||
| Total Current Assets | 434.93M | 510.76M | 552.63M | 535.59M | 296.59M |
| Net Property, Plant & Equipment | 40.61M | 41.63M | 29.45M | 30.58M | 31.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.26M | 2.86M | 2.32M | 771.00K | 684.00K |
| Total Assets | 560.38M | 604.03M | 620.12M | 629.88M | 339.89M |
|
|
|||||
| Total Accounts Payable | 4.39M | 2.92M | 3.43M | 4.22M | 3.52M |
| Total Accrued Expenses | 18.87M | 21.42M | 12.78M | 9.01M | 12.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.64M | 5.09M | 3.20M | 3.17M | 3.15M |
| Total Finance Division Other Current Liabilities | 257.00K | 35.00K | -- | -- | 273.00K |
| Total Other Current Liabilities | 257.00K | 35.00K | -- | -- | 273.00K |
| Total Current Liabilities | 29.15M | 29.47M | 19.40M | 16.40M | 18.95M |
|
|
|||||
| Total Current Liabilities | 29.15M | 29.47M | 19.40M | 16.40M | 18.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.97M | 19.74M | 10.46M | 11.00M | 11.52M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.66M | 1.87M | 1.91M | 1.92M | 1.59M |
| Total Liabilities | 49.78M | 51.08M | 31.78M | 29.32M | 32.06M |
|
|
|||||
| Common Stock & APIC | 1.09B | 1.08B | 1.07B | 1.05B | 723.14M |
| Retained Earnings | -576.20M | -526.52M | -482.68M | -447.73M | -415.33M |
| Treasury Stock & Other | 229.00K | 1.08M | -293.00K | -109.00K | 16.00K |
| Total Common Equity | 510.61M | 552.95M | 588.34M | 600.56M | 307.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 510.61M | 552.95M | 588.34M | 600.56M | 307.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 510.61M | 552.95M | 588.34M | 600.56M | 307.83M |
|
|
|||||
